发明名称 OXAZOLIDINONE AND/OR ISOXAZOLINE AS ANTIBACTERIAL AGENTS
摘要 Compounds of Formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, and compounds as shown in Formula (I) wherein C is for example (D), (E), (F); wherein A and B are independently selected from (i) and (ii); R2a to R3b are independently selected from hydrogen and fluorine; R1a and R1b are independently selected from, for example, hydroxy, -NHC(=W)R4, (a) and (b); wherein W is O or S; R4 is, for example, hydrogen, amino, (1-4C)alkyl; HET-1 is, for example, a C-linked 5-membered heteroaryl ring; HET-2 is, for example, an N-linked 5-membered, fully or partially unsaturated heterocyclic ring; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are described.
申请公布号 WO03022824(A1) 申请公布日期 2003.03.20
申请号 WO2002GB04120 申请日期 2002.09.09
申请人 ASTRAZENECA AB;ASTRAZENECA UK LIMITED;GRAVESTOCK, MICHAEL, BARRY;HALES, NEIL, JAMES;SWAIN, MICHAEL, LINGARD;HAUCK, SHEILA, IRENE;MILLS, STUART, DENNETT 发明人 GRAVESTOCK, MICHAEL, BARRY;HALES, NEIL, JAMES;SWAIN, MICHAEL, LINGARD;HAUCK, SHEILA, IRENE;MILLS, STUART, DENNETT
分类号 C07D261/04;A01N43/76;A01N43/80;A61K;A61K31/42;A61K31/422;A61K31/4439;A61P;A61P31/04;A61P43/00;C07D;C07D263/20;C07D263/24;C07D413/10;C07D413/12;C07D413/14;(IPC1-7):C07D263/24 主分类号 C07D261/04
代理机构 代理人
主权项
地址